Skip to content

Clinical trials

Observational Brain Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Observational Country / region: Netherlands Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20141
20151
20182
20192
20201
20211
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting4
Unknown status4
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UMC Utrecht2
Elisabeth-TweeSteden Ziekenhuis1
Erasmus Medical Center1
Jasper Gerritsen1
Leiden University Medical Center1
Nationwide Children's Hospital1
Robovision BV1
Sümeyye Sezer1
Telix Pharmaceuticals (Innovations) Pty Limited1
The Netherlands Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms14
Glioma5
Astrocytoma4
Glioblastoma4
Esophageal Neoplasms2
Neoplasm Metastasis2
Anxiety Disorders1
Breast Neoplasms1
Cystic Fibrosis1
Diffuse Intrinsic Pontine Glioma1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.